Tetrachlorodecaoxide

N/A

Report date: 2025/04/24 16:17:28

Base Information

Drug NameTetrachlorodecaoxide
Drug Alias NameRyoxonOxovirOxocebronAncloximexMacrokine +[17] 
ClassificationSmall molecules
Mechanisms of ActionScavenger receptor cysteine-rich type 1 protein M130 inhibitors
TargetsScavenger receptor cysteine-rich type 1 protein M130
Therapy Area/IndicationsInflammationDiabetic FootRhinitis, Allergic +[4] 
Global Approved IndicationsInflammationRhinitis, Allergic
Approved Indications in ChinaN/A
Original Approved Country/TerritoryThailand
Original Approved Date1997/01/01
Country/TerritoryCanadaUnited StatesThailand +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNuvox Pharma LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOxo Chemie GmbhSrinakharinwirot UniversityNuvo Research Gmbh +[4] 
Active IndicationsInflammationRhinitis, Allergic
Inactive IndicationsDiabetic FootHIV Infections

Other Information

ATC CodeR
Related LinksWikipediaDrugBank